What it does / how it works
Hits two gut-hormone receptors at once: GIP and GLP-1. The dual signal increases insulin when needed, lowers glucagon, slows gastric emptying and cuts hunger harder than GLP-1 alone in head-to-head work.
| Class | Dual GIP / GLP-1 agonist |
| Typical vial | 5–100 mg |
| Reconstitution | 1–2 mL BAC water |
| Storage after mix | 2–8°C, use within 28 days |
Protocol
| Goal | Dose | How often | How long | Route |
| Weeks 1-4 | 2.5 mg | Once weekly | 4 weeks | SubQ |
| Weeks 5-8 | 5 mg | Once weekly | 4 weeks | SubQ |
| Weeks 9-12 | 7.5 mg | Once weekly | 4 weeks | SubQ |
| Weeks 13-16 | 10 mg | Once weekly | 4 weeks | SubQ |
| Weeks 17-20 | 12.5 mg if needed | Once weekly | 4 weeks | SubQ |
|
Week 21 on |
5, 10 or 15 mg
maintenance (7.5 and 12.5 are steps) |
Once weekly |
Ongoing |
SubQ |
Watch: Never open at 10–15 mg. Trials spend 12–20 weeks reaching the top dose.